ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR)

CUSIP: N71542109

Q3 2017 13F Holders as of 30 Sep 2017

Type / Class
Equity / Ordinary Shares, nominal value Euro 0.04 per share
Shares outstanding
105,371,575
Total 13F shares
10,077,120
Share change
+1,059,448
Total reported value
$48,873,000
Price per share
$4.85
Number of holders
22
Value change
+$5,139,062
Number of buys
13
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP N71542109?
CUSIP N71542109 identifies PRQR - ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR) as of Q3 2017

As of 30 Sep 2017, ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR) was held by 22 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 10,077,120 shares. The largest 10 holders included JENNISON ASSOCIATES LLC, ORBIMED ADVISORS LLC, Redmile Group, LLC, Artal Group S.A., SPHERA FUNDS MANAGEMENT LTD., Clearbridge Investments, LLC, FRANKLIN RESOURCES INC, FMR LLC, ALTRINSIC GLOBAL ADVISORS LLC, and JANUS HENDERSON GROUP PLC. This page lists 22 institutional shareholders reporting positions in this security for the Q3 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.